Progress in the diagnosis and treatment of the urgency urinary incontinence in elder females

doi:10.3877/cma.j.issn.2095-8757.2016.02.009

Abstract

Abstract:

Urinary incontinence (UI) is common in elder women. Urgency urinary incontinence(UUI) is the common type of UI. Millions of women worldwide suffer from UUI nowadays, which seriously affects the health and life quality of female patients. With the aging of population in our country, the incidence of UUI increases. With the needs of quality of life rising gradually, the diagnosis and treatment of the disease are also increasingly valued and keeping step forward. However, there is still lack of one single and effective treatment for the disease, so that comprehensive treatments are used commonly. Here we make a review about the recent progress in diagnosis and treatment about UUI in elder women.

Key words: Urinary Incontinence, Urge, Diagnosis, Therapeutic uses, Aged, Women

Shuangshuang Zhong, Chunbo Yang, Hangmei Jin. Progress in the diagnosis and treatment of the urgency urinary incontinence in elder females[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2016, 03(02): 26-30.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlnbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8757.2016.02.009

https://zhlnbyjdzzz.cma-cmc.com.cn/EN/Y2016/V03/I02/26

References 27

[1]	Milsom I, Coyne KS, Nicholson S, et al. Global prevalence and economic burden of urgency urinary incontinence: a systematic review[J]. Eur Urol, 2014, 65(1): 79-95.
[2]	初磊，王建军，樊伯珍，等.上海市成年女性尿失禁的流行病学研究[J].现代妇产科进展，2015，27（6）：421-424.
[3]	Lu S, Zhang H, Zhang Y, et al. Prevalence and risk factors of urinary incontinence among perimenopausal women in Wuhan[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(5): 723-726.
[4]	Amundsen CL, Richter HE, Menefee SA, et al. Onabotulinumtoxin A vs sacral neuromodulation on refractory urgency urinary incontinence in women[J]. JAMA, 2015, Epub.
[5]	Caraway NP, Katz RL. A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis[J]. Cancer Cytopathol, 2010, 118(4): 175-183.
[6]	Sakakibara R, Tsunoyama K, Takahashi O, et al. Real-time measurement of oxyhemoglobin concentration changes in the frontal micturition area: an fNIRS study[J]. Neurourol Urodynam, 2010, 29(5): 757-764.
[7]	Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to bladder control[J]. Neurourol Urodyn, 2009, 29(1): 49-55.
[8]	Compérat E, Reitz A, Delcourt A, et al. Histologic Features in the urinary bladder wall affected from neurogenic overactivity-a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A[J]. Eur Urol, 2006,50(5): 1058-1064.
[9]	Karstens L, Asquith M, Davin S, et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity[J]? Front Cell Infect Microbiol, 2015, Epub.
[10]	Schmitz-Dräger BJ, Droller M, Lokeshwar VB, et al. Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus[J]. Urol Int, 2015, 94(1): 1-24.
[11]	Tse V, King J, Dowling C, et al. Conjoint urological society of Australia and New Zealand(USANZ) and urogynaecological society of Australasia(UGSA) guidelines on the management of adult non-neurogenic overactive bladder[J]. Bju Int, 2016, 117(1): 34-47.
[12]	Sherburn M, Bird M, Carey M, et al. Incontinence improves in older women after intensive pelvic floor muscle training: An assessor-blinded randomized controlled trial[J]. Neurourol Urodyn, 2011, 30(3): 317-324.
[13]	Schreiner L, Santos TG, Souza AB, et al. Electrical stimulation for urinary incontinence in women: a systematic review[J]. Int Braz J Urol, 2013, 39(4): 454-464.
[14]	Herderschee R, Hay-Smith EJ, Herbison GP, et al. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women[J]. Cochrane Database Syst Rev, 2011, 7: CD009252.
[15]	Olivera CK, Meriwether K, El-Nashar S, et al. Nonantimuscarinic treatment for overactive bladder: a systematic review[J].Am J Obstet Gynecol, 2016, 215(1): 34-57.
[16]	Gibson W, Athanasopoulos A, Goldman H, et al. Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence[J]? Int J Clin Pract, 2014, 68(9): 1165-1173.
[17]	Wagg A. Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder[J]. Res Rep Urol, 2012, 4: 57-64.
[18]	Aziminekoo E, Ghanbari Z, Hashemi S, et al. Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women[J]. J Family Reprod Health, 2014, 8(2): 73-76.
[19]	Singh-Franco D, Machado C, Tuteja S, et al. Trospium chloride for the treatment of overactive bladder with urge incontinence[J]. Clin Ther, 2005, 27(5): 511-530.
[20]	Kay GG, Ebinger U. Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin[J]. Int J Clin Pract, 2008, 62(11):1792-1800.
[21]	Vij M, Drake MJ. Clinical use of theβ3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome[J]. Ther Adv Urol, 2015, 7(5): 241-248.
[22]	Guo C, Yang B, Gu W, et al. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta- analysis[J]. PLoS One, 2013, 8(12): e82591.
[23]	Lazzeri M, Spinelli M, Zanollo A, et al. Intravesical vanilloids and neurogenic incontinence: ten years experience[J]. Urol Int, 2004, 72(2): 145-149.
[24]	Kuo H, Liu H, Chuang Y, et al. Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study[J]. Eur Urol, 2014, 65(6): 1117-1124.
[25]	Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review[J].J Urol, 2006, 175(3 PT 1): 835-841.
[26]	卫中庆.电刺激/调节技术在神经源性膀胱尿道功能障碍的临床应用[J].中华临床医师杂志（电子版），2012，6（13）：24-27.
[27]	Finazzi-AgròE, Petta F, Sciobica F, et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial[J].J Urol, 2010, 184(5): 2001-2006.

Please choose a citation manager

Content to export